Texts and EHR nudges aim to close the breast cancer screening gap

NCT ID NCT06177795

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether simple nudges—like text message reminders for patients and automatic mammogram orders for doctors—can increase breast cancer screening among women aged 40 to 74 who are overdue for a mammogram. The trial involves over 21,000 women at two health systems. Some participants receive text reminders to schedule their mammogram, while their doctors get a pre-filled order in the electronic health record. The goal is to see if these gentle pushes help more women complete screening within three to six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
text message reminders and electronic health record prompts
What this could lead to
If successful, this approach could provide a simple, scalable way to boost breast cancer screening rates, catching cancers earlier and saving lives.
What could go wrong
The trial tests behavioral nudges, not a new medical treatment, so the impact may be modest. Results depend on how well patients and clinicians respond to reminders, and may not apply to all healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Case Western Reserve University/University Hospitals

    Cleveland, Ohio, 44106, United States

  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.